NAFDAC ALERTS PUBLIC TO SUSPECTED COUNTERFEIT FORXIGA MEDICINES IN CIRCULATION. (PHOTO).

Image
 NAFDAC Alerts Public to Suspected Counterfeit Forxiga Medicines in Circulation The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the public to the circulation of suspected counterfeit medicinal products mimicking Forxiga (dapagliflozin) in the Nigerian market, warning that their use could pose serious health risks. The agency said the suspected counterfeit products were detected following market surveillance by pharmaceutical company AstraZeneca. The disclosure was contained in Public Alert No. 036/2026 posted on NAFDAC’s X handle on Thursday. According to the notice, AstraZeneca notified the agency after identifying products bearing names closely resembling Forxiga® and imitating the company’s brand identity and logo. Genuine Forxiga® (dapagliflozin) is prescribed to improve blood sugar control in people with Type 2 diabetes, reduce cardiovascular deaths and hospitalisations in patients with heart failure, and slow the progression of chronic ki...

META BEGINS TESTING INSTAGRAM PLUS, A PAID SUBSCRIPTION WITH EXCLUSIVE STORY FEATURES IN SELECT COUNTRIES. (PHOTO).


 Meta begins testing Instagram Plus, a paid subscription with exclusive Story features in select countries

Meta has started testing a new premium subscription for Instagram called Instagram Plus in select countries, giving users access to a range of exclusive features. The move comes two months after the company announced plans to experiment with paid subscriptions across Instagram, Facebook, and WhatsApp.

Instagram Plus allows subscribers to view Stories without notifying the poster, track how many people have rewatched their Stories, and create unlimited audience lists beyond the standard Close Friends option. Users can also extend a Story by 24 hours, spotlight one Story per week to boost visibility, give animated “Superlikes” on others’ Stories, and search their viewer list to quickly find a specific person. Reports indicate the trial is currently running in Mexico, Japan, and the Philippines, with prices ranging from roughly $1 to $2.20 per month depending on the country.

The subscription is separate from Meta Verified, which is aimed at content creators and businesses, and is intended for everyday users. While Meta aims to generate additional revenue through Instagram Plus, some users have expressed concerns over subscription fatigue. Competitors like Snapchat and X have shown there is demand for social media subscriptions, with Snapchat+ surpassing 25 million subscribers. Meta plans to continue testing Instagram Plus before expanding it further.


Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.